Hany Massarany, President and CEO at GenMark Diagnostics, Inc. (GNMK), sold 109,192 shares at $6.79 ($741K) on 2019-02-25, disclosed to the SEC on 2019-02-27.
Seasonal sale ($741k) by President and CEO — this insider has traded GNMK in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.79 | 54,596 | $371K | 50.0% |
| 2 | $6.79 | 54,596 | $371K | 50.0% |
| Total | $6.79 avg | 109,192 | $741K | 100% |
| Filing → |
| AXDX | BUY | 2022-02-01 | $66K | — | Filing → |
| AXDX | BUY | 2021-09-28 | $53K | — | Filing → |
| BDSX | BUY | 2020-11-03 | $135K | — | Filing → |